Alexander Kristen 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-02-28−10,617→ 21,233 total→ Common Stock (10,617 underlying) - Exercise/Conversion
Common Stock
2023-02-28+5,400→ 22,363 total - Exercise/Conversion
Common Stock
2023-02-28+2,700→ 25,063 total - Exercise/Conversion
Common Stock
2023-02-28+10,617→ 35,680 total - Exercise/Conversion
Restricted Stock Units
2023-02-28−5,400→ 0 total→ Common Stock (5,400 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-28−2,700→ 2,700 total→ Common Stock (2,700 underlying) - Tax Payment
Common Stock
2023-02-28$2.17/sh−5,330$11,566→ 30,350 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.